These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33254138)

  • 1. Predicting nonroutine discharge in patients undergoing surgery for vertebral column tumors.
    Ehresman J; Pennington Z; Feghali J; Schilling A; Hersh A; Hung B; Lubelski D; Sciubba DM
    J Neurosurg Spine; 2021 Mar; 34(3):364-373. PubMed ID: 33254138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel online calculator to predict nonroutine discharge, length of stay, readmission, and reoperation in patients undergoing surgery for intramedullary spinal cord tumors.
    Hersh AM; Patel J; Pennington Z; Antar A; Goldsborough E; Porras JL; Feghali J; Elsamadicy AA; Lubelski D; Wolinsky JP; Jallo GI; Gokaslan ZL; Lo SL; Sciubba DM
    Spine J; 2022 Aug; 22(8):1345-1355. PubMed ID: 35342014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of frailty metrics and the Charlson Comorbidity Index for predicting adverse outcomes in patients undergoing surgery for spine metastases.
    Hersh AM; Pennington Z; Hung B; Patel J; Goldsborough E; Schilling A; Feghali J; Antar A; Srivastava S; Botros D; Elsamadicy AA; Lo SL; Sciubba DM
    J Neurosurg Spine; 2022 May; 36(5):849-857. PubMed ID: 34826820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of race on nonroutine discharge, length of stay, and postoperative complications after surgery for spinal metastases.
    Hung B; Pennington Z; Hersh AM; Schilling A; Ehresman J; Patel J; Antar A; Porras JL; Elsamadicy AA; Sciubba DM
    J Neurosurg Spine; 2022 Apr; 36(4):678-685. PubMed ID: 34740176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital Frailty Risk Score and healthcare resource utilization after surgery for metastatic spinal column tumors.
    Elsamadicy AA; Koo AB; Reeves BC; Pennington Z; Yu J; Goodwin CR; Kolb L; Laurans M; Lo SL; Shin JH; Sciubba DM
    J Neurosurg Spine; 2022 Aug; 37(2):241-251. PubMed ID: 35148505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction calculator for nonroutine discharge and length of stay after spine surgery.
    Lubelski D; Ehresman J; Feghali J; Tanenbaum J; Bydon A; Theodore N; Witham T; Sciubba DM
    Spine J; 2020 Jul; 20(7):1154-1158. PubMed ID: 32179154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of nonroutine discharge among patients undergoing surgery for grade I spondylolisthesis: insights from the Quality Outcomes Database.
    Mummaneni PV; Bydon M; Knightly J; Alvi MA; Goyal A; Chan AK; Guan J; Biase M; Strauss A; Glassman S; Foley KT; Slotkin JR; Potts E; Shaffrey M; Shaffrey CI; Haid RW; Fu KM; Wang MY; Park P; Asher AL; Bisson EF
    J Neurosurg Spine; 2020 Apr; 32(4):523-532. PubMed ID: 31812142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical calculator for predicting intraoperative blood loss and transfusion risk in spine tumor patients.
    Pennington Z; Ehresman J; Feghali J; Schilling A; Hersh A; Hung B; Lubelski D; Sciubba DM
    Spine J; 2021 Feb; 21(2):302-311. PubMed ID: 33007469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for nonroutine discharge in adult spinal deformity surgery.
    Amin RM; Raad M; Jain A; Khashan M; Hassanzadeh H; Frank SM; Kebaish KM
    Spine J; 2019 Feb; 19(2):357-363. PubMed ID: 30661516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Outcomes and Health Care Resource Utilization After Surgical Intervention for Metastatic Spinal Column Tumor in Safety-Net Hospitals.
    Elsamadicy AA; Koo AB; David WB; Reeves BC; Sherman JJZ; Craft S; Hersh AM; Duvall J; Lo SL; Shin JH; Mendel E; Sciubba DM
    Spine (Phila Pa 1976); 2023 Jun; 48(11):800-809. PubMed ID: 36972069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race Is an Independent Predictor for Nonroutine Discharges After Spine Surgery for Spinal Intradural/Cord Tumors.
    Elsamadicy AA; Koo AB; David WB; Reeves BC; Freedman IG; Pennington Z; Ehresman J; Kolb L; Laurans M; Shin JH; Sciubba DM
    World Neurosurg; 2021 Jul; 151():e707-e717. PubMed ID: 33940256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of frailty in predictive modeling of short-term outcomes in the surgical management of metastatic tumors to the spine.
    Bakhsheshian J; Shahrestani S; Buser Z; Hah R; Hsieh PC; Liu JC; Wang JC
    Spine J; 2022 Apr; 22(4):605-615. PubMed ID: 34848345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Health Care Resource Utilization After Surgery for Metastatic Spinal Column Tumors in Patients with a Concurrent Affective Disorder in the United States.
    Elsamadicy AA; Koo AB; Sarkozy M; Reeves BC; Pennington Z; Havlik J; Sandhu MR; Hersh A; Patel S; Kolb L; Larry Lo SF; Shin JH; Mendel E; Sciubba DM
    World Neurosurg; 2022 May; 161():e252-e267. PubMed ID: 35123021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying patients at risk for nonroutine discharge after surgery for cervical myelopathy: an analysis from the Quality Outcomes Database.
    Mummaneni PV; Bydon M; Knightly JJ; Alvi MA; Yolcu YU; Chan AK; Foley KT; Slotkin JR; Potts EA; Shaffrey ME; Shaffrey CI; Fu KM; Wang MY; Park P; Upadhyaya CD; Asher AL; Tumialan L; Bisson EF
    J Neurosurg Spine; 2021 Jul; 35(1):25-33. PubMed ID: 33962388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of machine learning algorithms for prediction of discharge disposition after elective inpatient surgery for lumbar degenerative disc disorders.
    Karhade AV; Ogink P; Thio Q; Broekman M; Cha T; Gormley WB; Hershman S; Peul WC; Bono CM; Schwab JH
    Neurosurg Focus; 2018 Nov; 45(5):E6. PubMed ID: 30453463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tranexamic acid use on venous thromboembolism risk in patients undergoing surgery for spine tumors.
    Pennington Z; Ehresman J; Schilling A; Feghali J; Hersh AM; Hung B; Kalivas EN; Lubelski D; Sciubba DM
    J Neurosurg Spine; 2021 Nov; 35(5):663-673. PubMed ID: 34388705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Frailty Indices and Charlson Comorbidity Index for Predicting Adverse Outcomes in Patients Undergoing Surgery for Spine Metastases: A National Database Analysis.
    Elsamadicy AA; Havlik JL; Reeves B; Sherman J; Koo AB; Pennington Z; Hersh AM; Sandhu MRS; Kolb L; Larry Lo SF; Shin JH; Mendel E; Sciubba DM
    World Neurosurg; 2022 Aug; 164():e1058-e1070. PubMed ID: 35644519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Predictive Models for High-Value Care Outcomes Following Glioblastoma Resection.
    Nair SK; Chakravarti S; Jimenez AE; Botros D; Chiu I; Akbari H; Fox K; Jackson C; Gallia G; Bettegowda C; Weingart J; Mukherjee D
    World Neurosurg; 2022 May; 161():e572-e579. PubMed ID: 35196588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative analysis of the Hospital Frailty Risk Score in predicting postoperative outcomes among intracranial tumor patients.
    Jimenez AE; Liu J; Cicalese KV; Jimenez MA; Porras JL; Azad TD; Jackson C; Gallia GL; Bettegowda C; Weingart J; Mukherjee D
    J Neurosurg; 2023 Aug; 139(2):363-372. PubMed ID: 36577033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting High-Value Care Outcomes After Surgery for Non-Skull Base Meningiomas.
    Jimenez AE; Chakravarti S; Liu S; Wu E; Wei O; Shah PP; Nair S; Gendreau JL; Porras JL; Azad TD; Jackson CM; Gallia G; Bettegowda C; Weingart J; Brem H; Mukherjee D
    World Neurosurg; 2022 Mar; 159():e130-e138. PubMed ID: 34896348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.